These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2117445)

  • 21. Purification of staphylococcal exfoliative toxin by high pressure liquid chromatography.
    Sugai M; Inoue S; Hino T; Kuwabara M; Hong YM; Miyake Y; Suginaka H
    Zentralbl Bakteriol; 1990 May; 273(1):5-11. PubMed ID: 2363797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification of epidermolytic toxin of Staphylococcus aureus.
    de Azavedo JC; Bailey CJ; Arbuthnott JP
    Methods Enzymol; 1988; 165():32-6. PubMed ID: 3231110
    [No Abstract]   [Full Text] [Related]  

  • 23. Plasmids in epidermolytic strains of Staphylococcus aureus.
    O'Reilly M; Dougan G; Foster TJ; Arbuthnott JP
    J Gen Microbiol; 1981 May; 124(1):99-107. PubMed ID: 6275008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Staphylococcal scalded skin syndrome: detection of antibody to epidermolytic toxin by a primary binding assay.
    Baker DH; Wuepper KD; Rasmussen JE
    Clin Exp Dermatol; 1978 Mar; 3(1):17-24. PubMed ID: 348359
    [No Abstract]   [Full Text] [Related]  

  • 25. Structural determination of the essential serine and glycosylation sites of carboxypeptidase P.
    Zieske LR; Hsi KL; Chen L; Yuan PM
    Arch Biochem Biophys; 1992 May; 295(1):76-83. PubMed ID: 1575519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assays for epidermolytic toxin of Staphylococcus aureus.
    de Azavedo JC; Arbuthnott JP
    Methods Enzymol; 1988; 165():333-8. PubMed ID: 3148097
    [No Abstract]   [Full Text] [Related]  

  • 27. Purification and characterization of different types of exfoliative toxin from Staphylococcus aureus.
    Johnson AD; Spero L; Cades JS; de Cicco BT
    Infect Immun; 1979 Jun; 24(3):679-84. PubMed ID: 468373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding the mechanism of action of the exfoliative toxins of Staphylococcus aureus.
    Ladhani S
    FEMS Immunol Med Microbiol; 2003 Nov; 39(2):181-9. PubMed ID: 14625102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional and structural characterization of Spl proteases from Staphylococcus aureus.
    Popowicz GM; Dubin G; Stec-Niemczyk J; Czarny A; Dubin A; Potempa J; Holak TA
    J Mol Biol; 2006 Apr; 358(1):270-9. PubMed ID: 16516230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Staphylococcus aureus exfoliatin toxin in staphylococcal infections in mice.
    Shibl AM
    Chemotherapy; 1981; 27(3):224-7. PubMed ID: 7226975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of functionally active fragments of staphylococcal enterotoxin B.
    Alakhov VYu ; Klinsky EYu ; Kolosov MI; Maurer-Fogy I; Moskaleva EYu ; Sveshnikov PG; Pozdnyakova LP; Shemchukova OB; Severin ES
    Eur J Biochem; 1992 Nov; 209(3):823-8. PubMed ID: 1425690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active site of tripeptidyl peptidase II from human erythrocytes is of the subtilisin type.
    Tomkinson B; Wernstedt C; Hellman U; Zetterqvist O
    Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7508-12. PubMed ID: 3313395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nasal, axillary, and perineal carriage of Staphylococcus aureus among women: identification of strains producing epidermolytic toxin.
    Dancer SJ; Noble WC
    J Clin Pathol; 1991 Aug; 44(8):681-4. PubMed ID: 1890203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The search for strains of Staphylococcus aureus producing exfoliative toxin].
    Brevis P; Padilla C; Herrera R; Goset C
    Rev Latinoam Microbiol; 1988; 30(1):1-4. PubMed ID: 3140339
    [No Abstract]   [Full Text] [Related]  

  • 35. The amino-acid sequence of the double-headed proteinase inhibitor from badger (Meles meles) submandibular glands.
    Hochstrasser K; Paulus M; Wachter E; Reisinger PW
    Protein Seq Data Anal; 1989 Dec; 2(6):453-6. PubMed ID: 2626426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphorylation of P'(1) serine inhibits peptide bond sensitivity to Staphylococcus aureus V8 protease.
    Zambrano R; Briones E; Avila J; Ballesta JP
    Arch Biochem Biophys; 1999 Aug; 368(1):207-9. PubMed ID: 10415129
    [No Abstract]   [Full Text] [Related]  

  • 37. Cleavage by protease from Staphylococcus aureus V8: an improvement in the sequence analysis of human hemoglobin variants.
    Vasseur C; Galacteros F; Groff P; Wajcman H
    J Biochem Biophys Methods; 1991 Apr; 22(3):195-205. PubMed ID: 1865052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trypsin-catalysed formation of pig des-(23-63)-proinsulin from desoctapeptide-(B23-30)-insulin.
    Kubiak T; Cowburn D
    Biochem J; 1986 Mar; 234(3):665-70. PubMed ID: 3521594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycine reductase selenoprotein A is not a glycoprotein: the positive periodic acid-Schiff reagent test is the result of peptide bond cleavage and carbonyl group generation.
    Kimura Y; Stadtman TC
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2189-93. PubMed ID: 7892245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The primary structure of human apolipoprotein A-IV.
    Yang CY; Gu ZW; Chong IS; Xiong WJ; Rosseneu M; Yang HX; Lee BR; Gotto AM; Chan L
    Biochim Biophys Acta; 1989 Apr; 1002(2):231-7. PubMed ID: 2930771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.